(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes
Authors:
Open Access
- 1 January 2017
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 23 (32) , 5895-5903
Abstract
To investigate the effect of (-)-epigallocatechin-3-gallate (EGCG) on polyinosinic-polycytidylic acid (poly I:C)-triggered intracellular innate immunity against hepatitis C virus (HCV) in hepatocytes. A cell culture model of HCV infection was generated by infecting a hepatoma cell line, Huh7, with HCV JFH-1 strain (JFH-1-Huh7). Poly I:C with a high molecular weight and EGCG were used to stimulate the JFH-1-Huh7 cells. Real-time reverse transcription-polymerase chain reaction was used to detect the expression levels of intracellular mRNAs and of intracellular and extracellular HCV RNA. Enzyme-linked immunosorbent assay was used to evaluate the interferon (IFN)-λ1 protein level in the cell culture supernatant. Immunostaining was used to examine HCV core protein expression in Huh7 cells. Our recent study showed that HCV replication could impair poly I:C-triggered intracellular innate immune responses in hepatocytes. In the current study, we showed that EGCG treatment significantly increased the poly I:C-induced expression of Toll-like receptor 3 (TLR3), retinoic acid-inducible gene I, and IFN-λ1 in JFH-1-Huh7 cells. In addition, supplementation with EGCG increased the poly I:C-mediated antiviral activity in JFH-1-Huh7 cells at the intracellular and extracellular HCV RNA and protein levels. Further investigation of the mechanisms showed that EGCG treatment significantly enhanced the poly I:C-induced expression of IFN-regulatory factor 9 and several antiviral IFN-stimulated genes, including ISG15, ISG56, myxovirus resistance A, and 2’-5’-oligoadenylate synthetase 1, which encode the key antiviral elements in the IFN signaling pathway. Our observations provide experimental evidence that EGCG has the ability to enhance poly I:C-induced intracellular antiviral innate immunity against HCV replication in hepatocytes.Keywords
This publication has 46 references indexed in Scilit:
- Hepatitis C: global epidemiology and strategies for controlClinical Microbiology and Infection, 2016
- Neuroprotective Activity of ()-Epigallocatechin Gallate against Lipopolysaccharide-Mediated CytotoxicityJournal of Immunology Research, 2016
- Polyphenon E®, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosisCarcinogenesis, 2013
- Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver culturesHepatology, 2010
- Phase 1b Study of Pegylated Interferon Lambda 1 With or Without Ribavirin in Patients with Chronic Genotype 1 Hepatitis C Virus Infection†Hepatology, 2010
- Toll‐like Receptor and RIG‐1‐like Receptor SignalingAnnals of the New York Academy of Sciences, 2008
- The Natural History of Hepatitis C Virus (HCV) InfectionInternational Journal of Medical Sciences, 2006
- Antiviral effect of catechins in green tea on influenza virusAntiviral Research, 2005
- Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signalingProceedings of the National Academy of Sciences, 2005
- Combination Therapy with Interferon and Ribavirin in the Treatment of Chronic Hepatitis C InfectionAnnals of Pharmacotherapy, 2000